Trust & Proof: Integra LifeSciences – Signal Evidence & AI Readability

Integra LifeSciences

(https://integralife.com) 📸 Data Snapshot: May 30, 2026
Trust & Proof — The Lens

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Trust & Proof Verifiable evidence vs. Trust Theatre.
17 Impact Weight: 20 / 100
85% Reputation

The site avoids trust theatre by maintaining a review_count of 0, eschewing the common ‘unverified testimonial’ trap. Proof is provided through regulatory milestones, such as the mention of ‘FDA 510(k) Clearance for CUSA Clarity’ and ‘first patient enrolled’ in registries. While the ESG page contains some corporate fluff, the presence of specific ‘Archived Reports’ from 2021-2023 provides a chronological proof path.

The proof density is high for an enterprise site. Verifiable evidence includes specific FDA clearance codes (510(k)), named product lines (CUSA Clarity, Acclarent AERA), and a highly granular contact directory for 20+ countries. This outweighs the vague assertions found in the ESG sections, moving the site firmly into the substance-heavy category.

Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.

🛡️ Trust Signals — reviews, proof links, trust-theatre check
0Review mentions (all pages)
4External proof links (all pages)
PageReviewsProof links
/ (home) 0 1
/news/ 0 1
/esg-report/ 0 1
/contact/ 0 1
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage — no schema detected (entity gap)
/news/ — no schema detected (entity gap)
/esg-report/ — no schema detected (entity gap)
/contact/ — no schema detected (entity gap)